Estimating required information size by quantifying diversity in random-effects model meta-analyses

BackgroundThere is increasing awareness that meta-analyses require a sufficiently large information size to detect or reject an anticipated intervention effect. The required information size in a meta-analysis may be calculated from an anticipated a priori intervention effect or from an intervention effect suggested by trials with low-risk of bias.MethodsInformation size calculations need to consider the total model variance in a meta-analysis to control type I and type II errors. Here, we derive an adjusting factor for the required information size under any random-effects model meta-analysis.ResultsWe devise a measure of diversity (D2) in a meta-analysis, which is the relative variance reduction when the meta-analysis model is changed from a random-effects into a fixed-effect model. D2 is the percentage that the between-trial variability constitutes of the sum of the between-trial variability and a sampling error estimate considering the required information size. D2 is different from the intuitively obvious adjusting factor based on the common quantification of heterogeneity, the inconsistency (I2), which may underestimate the required information size. Thus, D2 and I2 are compared and interpreted using several simulations and clinical examples. In addition we show mathematically that diversity is equal to or greater than inconsistency, that is D2 ≥ I2, for all meta-analyses.ConclusionWe conclude that D2 seems a better alternative than I2 to consider model variation in any random-effects meta-analysis despite the choice of the between trial variance estimator that constitutes the model. Furthermore, D2 can readily adjust the required information size in any random-effects model meta-analysis.

[1]  S. Yusuf,et al.  Overcoming the limitations of current meta-analysis of randomised controlled trials , 1998, The Lancet.

[2]  Jørn Wetterslev,et al.  Benefits and harms of perioperative beta-blockade. , 2006, Best practice & research. Clinical anaesthesiology.

[3]  Julian P T Higgins,et al.  Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. , 2008, International journal of epidemiology.

[4]  I. Williams,et al.  SCHAUM ' S OUTLINE ' SERIES , 2022 .

[5]  Christian Gluud,et al.  Perioperative β blockers in patients having non-cardiac surgery: a meta-analysis , 2008, The Lancet.

[6]  R. Soll,et al.  Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants. , 2000, The Cochrane database of systematic reviews.

[7]  S. Yusuf,et al.  Strengths and limitations of meta-analysis: larger studies may be more reliable. , 1997, Controlled clinical trials.

[8]  Gerta Rücker,et al.  Are large trials less reliable than small trials? , 2009, Journal of clinical epidemiology.

[9]  Pietro Caliandro,et al.  Treatment for ulnar neuropathy at the elbow. (Protocol) , 2007 .

[10]  Kristian Thorlund,et al.  Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses? , 2009, International journal of epidemiology.

[11]  Stephen B. Gruber,et al.  Clinical Epidemiology: The Architecture of Clinical Research , 1986, The Yale Journal of Biology and Medicine.

[12]  Gerta Rücker,et al.  Bmc Medical Research Methodology Open Access Undue Reliance on I 2 in Assessing Heterogeneity May Mislead , 2022 .

[13]  V. Fedorov,et al.  The design of multicentre trials , 2005, Statistical methods in medical research.

[14]  A. Hrõbjartsson,et al.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. , 2004, JAMA.

[15]  D. Spiegelman,et al.  Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis. , 1999, American journal of epidemiology.

[16]  Gordon H Guyatt,et al.  How strong is the evidence for the use of perioperative β blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials , 2005, BMJ : British Medical Journal.

[17]  Douglas G Altman,et al.  Meta-analysis, Simpson's paradox, and the number needed to treat , 2002, BMC medical research methodology.

[18]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[19]  Jørn Wetterslev,et al.  Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis , 2007, BMJ : British Medical Journal.

[20]  Kristian Thorlund,et al.  Apparently conclusive meta-analyses may be inconclusive--Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. , 2009, International journal of epidemiology.

[21]  A. Abou-Setta,et al.  Gonadotrophin-releasing hormone antagonists for assisted conception. , 2006, The Cochrane database of systematic reviews.

[22]  Douglas G Altman,et al.  Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study , 2008, BMJ : British Medical Journal.

[23]  Nikolaos A Patsopoulos,et al.  Uncertainty in heterogeneity estimates in meta-analyses , 2007, BMJ : British Medical Journal.

[24]  A. Bauhofer,et al.  Antithrombin III in critically ill patients , 2007, BMJ : British Medical Journal.

[25]  H. Handoll,et al.  Interventions for replacing missing teeth: different times for loading dental implants. , 2004, The Cochrane database of systematic reviews.

[26]  Gordon H Guyatt,et al.  Randomized trials stopped early for benefit: a systematic review. , 2005, JAMA.

[27]  K. Thorlund,et al.  Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. , 2008, Journal of clinical epidemiology.

[28]  K. Thorlund,et al.  Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. , 2008, Journal of clinical epidemiology.

[29]  M. R. Spiegel Mathematical handbook of formulas and tables , 1968 .

[30]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[31]  Gordon H Guyatt,et al.  In the Era of Systematic Reviews, Does the Size of an Individual Trial Still Matter? , 2008, PLoS medicine.

[32]  J. Ioannidis,et al.  Extreme between-study homogeneity in meta-analyses could offer useful insights. , 2006, Journal of clinical epidemiology.

[33]  Kurex Sidik,et al.  A comparison of heterogeneity variance estimators in combining results of studies , 2007, Statistics in medicine.

[34]  S. Yusuf,et al.  Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. , 1997, Controlled clinical trials.

[35]  Jørn Wetterslev,et al.  Perioperative oxygen fraction – effect on surgical site infection and pulmonary complications after abdominal surgery: a randomized clinical trial. Rationale and design of the PROXI-Trial , 2008, Trials.

[36]  L. Gluud Bias in clinical intervention research. , 2006, American journal of epidemiology.

[37]  M Egger,et al.  Intravenous magnesium for acute myocardial infarction. , 2007, The Cochrane database of systematic reviews.

[38]  D. Altman,et al.  Identifying outcome reporting bias in randomised trials on PubMed: review of publications and survey of authors , 2005, BMJ : British Medical Journal.

[39]  E. Özek,et al.  Prophylactic animal derived surfactant extract for preventing morbidity and mortality in preterm infants , 1997 .

[40]  D. Tudehope,et al.  Enteral antibiotics for preventing necrotizing enterocolitis in low birthweight or preterm infants. , 2001, The Cochrane database of systematic reviews.

[41]  A. Feinstein,et al.  Clinical Epidemiology: The Architecture of Clinical Research. , 1987 .